IO Learning invited Allison S. Aguado, MD, to discuss her 2021 Society of Interventional Radiology (SIR) presentation on the efficacy of minimally invasive interventional radiology treatments in pediatric cancer patients.
IO Learning spoke with Dr David Lacey, who was one of the first interventionists in the United States to utilize the Siemens Angio-CT, and was instrumental in the development of the current generation, Nexaris.
IO Learning spoke with Riccardo Lencioni, MD, FSIR, EBIR, regarding the trial design for the EMERALD-1 study, which was recently presented at CIO 2020 and was designated as a “CIO Best Poster.”
There is increasing evidence to support the concept of ablative-intent radioembolization, but the literature remains sparse for solitary HCC. We spoke with S. Ali Montazeri, MD, MPH, who presented his research on this topic at CIO 2020.
IO Learning invited Dr Nishita Kothary to discuss her 2020 SIR abstract, “Comparison of Drug-Eluting Beads versus Conventional Transarterial Chemoembolization: A Cost-Effectiveness Analysis.”
Dr Fabian Laage Gaupp, co-founder of the Tanzanian IR Initiative, discusses the current status of the program, as well as challenges faced during the COVID pandemic.
IO Learning invited Bela Kis, MD, PhD, to discuss his 2020 SIR Abstract of the Year, “Transarterial Chemoperfusion Treatment of Unresectable Pleural Mesothelioma: Interim Results of a Phase 2 Prospective Study.”
Dr Ripal Gandhi discusses his 2020 SIR abstract, “Overcoming Limitations in the Treatment of
Locally Advanced Pancreatic Cancer With Transarterial Microperfusion Utilizing a Novel Dual-Balloon Catheter."
Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.